Our findings reveal a precise mechanism by which NPRL2 antagonizes PRRSV by targeting a critical viral protein for autophagic degradation, highlighting the therapeutic potential of harnessing the host's ubiquitin-autophagy pathway to combat viral infections. The gene discussed is NPRL2; the disease is viral infectious disease.